ACHILLION PHARMACEUTICALS IN's ticker is ACHN and the CUSIP is 00448Q201. A total of 126 filers reported holding ACHILLION PHARMACEUTICALS IN in Q1 2018. The put-call ratio across all filers is 0.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $10,542,000 | +71.1% | 1,748,286 | +2.1% | 0.00% | +100.0% |
| Q3 2019 | $6,161,000 | +42.9% | 1,711,592 | +6.4% | 0.00% | 0.0% |
| Q2 2019 | $4,311,000 | -10.4% | 1,608,511 | -1.0% | 0.00% | 0.0% |
| Q1 2019 | $4,809,000 | +87.3% | 1,624,873 | +0.6% | 0.00% | 0.0% |
| Q4 2018 | $2,567,000 | -57.2% | 1,615,092 | -0.8% | 0.00% | 0.0% |
| Q3 2018 | $5,992,000 | +32.0% | 1,628,422 | +1.5% | 0.00% | 0.0% |
| Q2 2018 | $4,541,000 | -22.2% | 1,604,822 | +1.9% | 0.00% | -50.0% |
| Q1 2018 | $5,840,000 | +40.6% | 1,574,153 | +9.1% | 0.00% | +100.0% |
| Q4 2017 | $4,155,000 | -35.2% | 1,442,934 | +1.1% | 0.00% | -50.0% |
| Q3 2017 | $6,408,000 | -2.2% | 1,427,280 | +0.0% | 0.00% | 0.0% |
| Q2 2017 | $6,549,000 | +4.8% | 1,426,821 | -3.9% | 0.00% | 0.0% |
| Q1 2017 | $6,249,000 | +4.8% | 1,484,518 | +2.8% | 0.00% | 0.0% |
| Q4 2016 | $5,962,000 | -48.7% | 1,443,544 | +0.6% | 0.00% | -50.0% |
| Q3 2016 | $11,626,000 | +2.1% | 1,435,252 | -1.7% | 0.00% | 0.0% |
| Q2 2016 | $11,388,000 | +6.8% | 1,459,960 | +5.7% | 0.00% | 0.0% |
| Q1 2016 | $10,666,000 | -27.6% | 1,381,467 | +1.2% | 0.00% | -20.0% |
| Q4 2015 | $14,735,000 | +55.9% | 1,365,563 | -0.2% | 0.01% | +66.7% |
| Q3 2015 | $9,452,000 | -10.5% | 1,367,822 | +14.8% | 0.00% | 0.0% |
| Q2 2015 | $10,555,000 | -16.1% | 1,191,294 | -6.7% | 0.00% | -25.0% |
| Q1 2015 | $12,585,000 | -3.0% | 1,276,379 | +20.5% | 0.00% | 0.0% |
| Q4 2014 | $12,971,000 | +20.3% | 1,058,850 | -2.0% | 0.00% | +33.3% |
| Q3 2014 | $10,781,000 | +32.1% | 1,080,260 | +0.2% | 0.00% | 0.0% |
| Q2 2014 | $8,159,000 | +98.2% | 1,077,812 | -13.9% | 0.00% | +200.0% |
| Q1 2014 | $4,117,000 | -9.5% | 1,251,152 | -8.7% | 0.00% | 0.0% |
| Q4 2013 | $4,549,000 | +9.5% | 1,370,716 | -0.4% | 0.00% | 0.0% |
| Q3 2013 | $4,155,000 | -57.0% | 1,375,874 | +16.6% | 0.00% | -66.7% |
| Q2 2013 | $9,656,000 | – | 1,180,395 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 13,633,220 | $57,396,000 | 7.04% |
| HealthInvest Partners AB | 497,807 | $2,096,000 | 3.21% |
| BVF INC/IL | 3,285,400 | $13,832,000 | 2.35% |
| EMORY UNIVERSITY | 486,438 | $2,048,000 | 1.93% |
| Marcus Capital, LLC | 69,400 | $1,751,000 | 1.63% |
| DAFNA Capital Management LLC | 196,500 | $827,000 | 0.70% |
| Orbimed Advisors | 13,107,200 | $55,181,000 | 0.62% |
| Rock Springs Capital Management LP | 1,500,000 | $6,315,000 | 0.36% |
| Spark Investment Management LLC | 710,100 | $2,989,000 | 0.19% |
| TURNER INVESTMENTS LLC | 65,420 | $275,000 | 0.18% |